Catalyst Wire Dossier Catalyst Wire Dossier

MK-8931

MK-8931 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8931, covering 2018-10-01 to 2018-10-01. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) [Phase 1]

See pricing